Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 55

1.

Efficacy and Safety of Cilostazol Therapy in Ischemic Stroke: A Meta-analysis.

Tan L, Margaret B, Zhang JH, Hu R, Yin Y, Cao L, Feng H, Zhang Y.

J Stroke Cerebrovasc Dis. 2015 May;24(5):930-8. doi: 10.1016/j.jstrokecerebrovasdis.2014.12.002. Epub 2015 Mar 21.

PMID:
25804574
3.

Low-dose aspirin for primary prevention of cardiovascular events in Japanese patients 60 years or older with atherosclerotic risk factors: a randomized clinical trial.

Ikeda Y, Shimada K, Teramoto T, Uchiyama S, Yamazaki T, Oikawa S, Sugawara M, Ando K, Murata M, Yokoyama K, Ishizuka N.

JAMA. 2014 Dec 17;312(23):2510-20. doi: 10.1001/jama.2014.15690.

PMID:
25401325
4.

Prevention of cardiovascular disease in women.

Bavry AA, Limacher MC.

Semin Reprod Med. 2014 Nov;32(6):447-53. doi: 10.1055/s-0034-1384628. Epub 2014 Oct 16.

PMID:
25321422
5.

Polypill for the prevention of cardiovascular disease (PolyIran): study design and rationale for a pragmatic cluster randomized controlled trial.

Ostovaneh MR, Poustchi H, Hemming K, Marjani H, Pourshams A, Nateghi A, Majed M, Navabakhsh B, Khoshnia M, Jaafari E, Mohammadifard N, Malekzadeh F, Merat S, Sadeghi M, Naemi M, Etemadi A, Thomas GN, Sarrafzadegan N, Cheng K, Marshall T, Malekzadeh R.

Eur J Prev Cardiol. 2014 Sep 17. pii: 2047487314550803. [Epub ahead of print]

PMID:
25230980
6.

Estimates of benefits and harms of prophylactic use of aspirin in the general population.

Cuzick J, Thorat MA, Bosetti C, Brown PH, Burn J, Cook NR, Ford LG, Jacobs EJ, Jankowski JA, La Vecchia C, Law M, Meyskens F, Rothwell PM, Senn HJ, Umar A.

Ann Oncol. 2015 Jan;26(1):47-57. doi: 10.1093/annonc/mdu225. Epub 2014 Aug 5.

7.

Do clinicians recommend aspirin to patients for primary prevention of cardiovascular disease?

Fiscella K, Winters PC, Mendoza M, Noronha GJ, Swanger CM, Bisognano JD, Fortuna RJ.

J Gen Intern Med. 2015 Feb;30(2):155-60. doi: 10.1007/s11606-014-2985-8.

PMID:
25092016
8.

Nonsteroidal anti-inflammatory drugs and cardiovascular outcomes in women: results from the women's health initiative.

Bavry AA, Thomas F, Allison M, Johnson KC, Howard BV, Hlatky M, Manson JE, Limacher MC.

Circ Cardiovasc Qual Outcomes. 2014 Jul;7(4):603-10. doi: 10.1161/CIRCOUTCOMES.113.000800. Epub 2014 Jul 8.

PMID:
25006185
9.

Association of cyclooxygenase-2 genetic variant with cardiovascular disease.

Ross S, Eikelboom J, Anand SS, Eriksson N, Gerstein HC, Mehta S, Connolly SJ, Rose L, Ridker PM, Wallentin L, Chasman DI, Yusuf S, Paré G.

Eur Heart J. 2014 Sep 1;35(33):2242-8a. doi: 10.1093/eurheartj/ehu168. Epub 2014 May 5.

PMID:
24796340
10.

Atrial fibrillation and the risk of myocardial infarction.

Soliman EZ, Safford MM, Muntner P, Khodneva Y, Dawood FZ, Zakai NA, Thacker EL, Judd S, Howard VJ, Howard G, Herrington DM, Cushman M.

JAMA Intern Med. 2014 Jan;174(1):107-14. doi: 10.1001/jamainternmed.2013.11912. Erratum in: JAMA Intern Med. 2014 Feb 1;174(2):308.

11.

Predictors of 1-year outcomes in the Taiwan Acute Coronary Syndrome Full Spectrum Registry.

Chiang FT, Shyu KG, Wu CJ, Mar GY, Hou CJ, Li AH, Wen MS, Lai WT, Lin SJ, Kuo CT, Kuo C, Li YH, Hwang JJ; ACS Full Spectrum Registry Investigators.

J Formos Med Assoc. 2014 Nov;113(11):794-802. doi: 10.1016/j.jfma.2013.08.001. Epub 2013 Sep 26.

PMID:
24076272
12.

Optimal medical treatment versus carotid endarterectomy: the rationale and design of the Aggressive Medical Treatment Evaluation for Asymptomatic Carotid Artery Stenosis (AMTEC) study.

Kolos I, Loukianov M, Dupik N, Boytsov S, Deev A.

Int J Stroke. 2015 Feb;10(2):269-74. doi: 10.1111/ijs.12019. Epub 2013 Mar 15.

PMID:
23490405
13.

Antiplatelet therapy in acute coronary syndrome and atrial fibrillation: aspirin.

Tanguay JF.

Adv Cardiol. 2012;47:20-30. doi: 10.1159/000338056. Epub 2012 Aug 9. Review.

PMID:
22906900
14.

Benefits versus risks of aspirin in cardioprotection: dangers of heart attack after discontinuation.

Wynn RL.

Gen Dent. 2012 Jul-Aug;60(4):255-8. No abstract available.

PMID:
22782034
15.

Asymptomatic individuals with a positive family history for premature coronary artery disease and elevated coronary calcium scores benefit from statin treatment: a post hoc analysis from the St. Francis Heart Study.

Mulders TA, Sivapalaratnam S, Stroes ES, Kastelein JJ, Guerci AD, Pinto-Sietsma SJ.

JACC Cardiovasc Imaging. 2012 Mar;5(3):252-60. doi: 10.1016/j.jcmg.2011.11.014.

16.

Cardiovascular disease risk factors: prevalence and management in adult hemophilia patients.

Lim MY, Pruthi RK.

Blood Coagul Fibrinolysis. 2011 Jul;22(5):402-6. doi: 10.1097/MBC.0b013e328345f582.

PMID:
21451396
17.

Knowledge, attitudes and current practice of Jordanian family physicians about prescribing aspirin in primary and secondary prevention of vascular diseases: a self-reported survey.

Al Omari M, Khader Y, Al-azzam SI, Dauod AS, Khassawneh AH, Alomari N, Alzoubi KH.

Eur J Cardiovasc Nurs. 2012 Mar;11(1):9-13. doi: 10.1016/j.ejcnurse.2010.09.003.

PMID:
20933473
18.

USPSTF recommendations you may have missed amid the breast cancer controversy.

Campos-Outcalt D.

J Fam Pract. 2010 May;59(5):276-80.

PMID:
20544048
19.

Physical functional health predicts the incidence of coronary heart disease in the European Prospective Investigation into Cancer-Norfolk prospective population-based study.

Myint PK, Luben RN, Surtees PG, Wainwright NW, Wareham NJ, Khaw KT.

Int J Epidemiol. 2010 Aug;39(4):996-1003. doi: 10.1093/ije/dyq061. Epub 2010 Apr 25.

20.

Type 2 diabetes: Which interventions best reduce absolute risks of adverse events?

Firestone B, Mold JW.

J Fam Pract. 2009 Jun;58(6):E1.

PMID:
19508839
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk